Nürnberger Beteiligungs — New business growth and changes to ZZR

Nurnberger Beteiligungs (DB: NBG6)

Last close As at 18/03/2024

79.50

−0.50 (−0.63%)

Market capitalisation

915m

More on this equity

Research: Financials

Nürnberger Beteiligungs — New business growth and changes to ZZR

Nürnberger Beteiligungs’ (NBG’s) FY18 results reflect an overall stable business at the top line, as gross premiums booked were up by 2.2% versus FY17 and new business was ahead of management expectations. However, the bottom line continues to be affected by the low interest rates translating into weaker net investment income (although a high base from one-off effects in FY17 played a role as well). This should also reduce earnings in FY19, with the current guidance implying a 10% y-o-y decline. On the other hand, the recent introduction of the ‘corridor method’ in case of the Zinszusatzreserve (ZZR) provided some tailwinds in FY18.

Milosz Papst

Written by

Milosz Papst

Director, Financials

Financials

Nürnberger Beteiligungs

New business growth and changes to ZZR

Insurance

Scale research report - Update

3 April 2019

Price

€70.5

Market cap

€812m

Share price graph

Share details

Code

NBG6

Listing

Deutsche Börse Scale

Shares in issue

11.52m

Liquid resources at 31 December 2018

€375.8m

Business description

Nürnberger Beteiligungs is the parent company of a group of insurers and financial service companies. It is one of Germany’s oldest insurers operating since 1884. Nürnberger Beteiligungs offers life, health and property and casualty insurance, with strongest demand for unit-linked life, disability and pension insurance and standard pension insurance.

Bull

Very strong finances and conservative reporting.

Well-established brand name and solid historical performance.

Stable annual dividend payments.

Bear

Low interest rate environment.

Regulatory uncertainty.

Highly competitive industry.

Analyst

Milosz Papst

+44 (0)20 3077 5700

Nürnberger Beteiligungs’ (NBG’s) FY18 results reflect an overall stable business at the top line, as gross premiums booked were up by 2.2% versus FY17 and new business was ahead of management expectations. However, the bottom line continues to be affected by the low interest rates translating into weaker net investment income (although a high base from one-off effects in FY17 played a role as well). This should also reduce earnings in FY19, with the current guidance implying a 10% y-o-y decline. On the other hand, the recent introduction of the ‘corridor method’ in case of the Zinszusatzreserve (ZZR) provided some tailwinds in FY18.

FY18 results ahead of management guidance

NBG has reported a net profit of €60.8m, down from €99.5m in FY17 but ahead of company guidance of €50m. The earnings beat was driven by several factors, including a more limited increase in reserves on the back of recent regulatory changes related to the ZZR and a solid level of new premiums in the life insurance business (up 7.0% y-o-y), translating into broadly stable gross premiums at €2.5bn. Moreover, the Property and Casualty (P&C) business was able to improve its combined ratio to 91.4% from 95.3% in FY17. NBG’s high exposure to unit-linked and disability products reduces the impact of low interest rates on its business.

Cautious outlook underpinned by market factors

As the insurance industry in Germany continues to be shaped by low interest rates and strict regulations (in particular in the life insurance segment), NBG has issued relatively conservative guidance, with net profit forecasted at €55m, implying a c 10% y-o-y decline. The key reason behind this should be lower investment income (in particular realised gains). Gross premiums booked are expected to remain stable in life insurance but increase in the P&C and health insurance segments. Given the high proportion of life insurance business, this should translate into broadly stable premiums at group level, coupled with a slight increase in new business. NBG’s actuarial result should be in line with FY18.

Valuation: Trading at a premium to peers

Based on the company’s net income guidance for FY19, NBG’s shares are traded at a c 40% premium to peer group on P/E ratio. Based on the declared dividend of €3.0 per share (which has remained stable since 2013), the shares offer a dividend yield of c 4.3%, with further space to grow in the future.

Historical performance

Year
end

Revenue
(€m)

PBT

(€m)

EPS

(€)

DPS
(€)

P/E

(x)

Yield
(%)

12/15

4,658

85.4

4.1

3.0

17.2

4.3

12/16

4,189

88.1

5.0

3.0

14.1

4.3

12/17

4,387

147.3

8.1

3.0

8.7

4.3

12/18

4,404

97.3

5.1

3.0

13.8

4.3

Source: Nürnberger Beteiligungs accounts

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

FY18 results: Earnings down due to investment income

NBG reported a 2.2% y-o-y increase in gross premiums booked to €3.5bn, which is broadly in line with management’s guidance of a slight increase across its segments. This is in line with the increase in gross premiums booked by 2.1% y-o-y to €202.2bn in 2018 in the German insurance industry reported by the Gesamtverband der Deutschen Versicherungswirtschaft (GDV). At the same time, NBG’s new premiums went up by a solid 7.8% y-o-y to €555.9m, ahead of the earlier management expectations of a slight decline in new business. This €40m y-o-y increase was mostly attributable to life insurance (€28.1m), but also property and casualty business (P&C, €11.7m). In the latter case, the main driver was the full consolidation of Neue Rechtsschutz-Versicherung (NRV, acquired in Q317).

Together with the somewhat lower gross investment income at €877.9m (vs €931.2m in FY17) and commission income at €47.6m (€53.4m in FY17), total group revenues improved marginally by 0.4% y-o-y to €4.4bn. Net investment income related to the standard insurance business reached €730.3m (down 6.5% y-o-y), with higher disposals gains of €212.8m (vs €154.0m in FY17) offset by the lower current income at €617.9m (FY17: €708.0m). The latter is the result of high base from one-time effects in FY17 (distributions from two special funds) and lower income from other investments (primarily private equity) in FY18, presumably due to the more challenging market environment towards the end of the year.

NBG’s life insurance business (representing c 70% of gross premiums in FY18) was further supported by recent changes implemented by the German regulator (BaFin) in the calculation of Zinszusatzreserve (ZZR, see detailed discussion below). Consequently, the ZZR increase in the case of NBG stood at €61.3m in FY18, in comparison to €241.3m in FY17. Overall, other technical provisions stood at a positive €448.5m compared with a negative €1,571.1m, predominantly as a result of the negative capital market developments translating into lower provisions associated with unit-linked products (as distributions are not a fixed pre-set level here, but are dependent on the performance of the underlying investment portfolio within the insurance product). However, the latter is by definition accompanied by an opposite move in unrealised profits/losses from unit-linked insurance investments booked by NBG (a negative €1.1bn in FY18 compared with positive €723.5m in FY17). Hence, these two items have a relatively limited impact on the bottom line.

Claims expenses went up only slightly by 1.2% y-o-y to €2.3bn in FY18 despite the 9.8% y-o-y increase posted in H118. Operating expenses went up by 10.8% y-o-y to €558.9m on the back of higher acquisition costs (€425.2m vs €382.5m in FY17, largely associated with new business) as well as G&A expenses (€212.7m vs €187.8m) due to NRV consolidation and investments in process optimisation (including the implementation of new IT solutions). As a result of the above, NBG has reported net income at €60.8m, well above management guidance of €50m. This represents a c 39% y-o-y decline, which is partially the effect of higher comparative base due to a one-off effect from asset disposal in H117. After adjusting for minorities, net income stood at €58.8m, representing an ROE of around 7.4%.

Exhibit 1: Results highlights

€m

FY18

FY17

y-o-y

Gross premiums booked

3,478.1

3,402.6

2.2%

Premiums earned

3,216.9

3,165.1

1.6%

Net result on premium refunds

(354.9)

(187.7)

89.1%

Investment income

736.4

833.1

-11.6%

Unrealized profits/losses from unit-linked insurance investments

(1,050.4)

723.5

N/M

Other net technical income/(expense)

(24.4)

(48.7)

-49.8%

Claims expenses

(2,290.9)

(2,264.5)

1.2%

Change in other technical provisions

448.5

(1,571.1)

N/M

Operating expenses

(558.9)

(504.3)

10.8%

Change in equalisation and other reserves

(15.7)

12.5

N/M

Other net (non-technical) income/(expense)

(11.3)

(14.4)

-21.2%

Goodwill amortisation

(0.6)

(0.5)

19.4%

Extraordinary result

2.6

4.3

-38.5%

Pre-tax profit

97.3

147.3

-34.0%

Income and other taxes

(36.4)

(47.8)

-23.7%

Net income (incl. minorities)

60.8

99.5

-38.9%

Minorities

(2.0)

(6.5)

-68.4%

Net income (ex-minorities)

58.8

93.1

-36.8%

Source: NBG accounts, Edison Investment Research

Segment analysis

The life insurance segment result declined by 31.6% y-o-y to €44.0m, which was due to lower net investment income (down 10% to €662.3m) and a slight increase in claims expenses by 1.5% y-o-y to €1.8bn. Still, this was ahead of company guidance of €38m and was assisted by a healthy increase in new premiums of 7.0% y-o-y to €430.1m in FY18, with single-premium business growing 7.6% y-o-y (ahead of the market at 3.7% in 2018, according to GDV). As a result, gross premiums stabilised at around €2.5bn; earlier company expectations had been for a slight decline. This compares with gross premiums growth in the German market at 1.4% in 2018. In this segment, NBG’s focus is on income protection (due to growing market penetration) and unit-linked products.

Moreover, the life insurance result was assisted by the introduction of the ‘corridor method’ to establish the reference rate for the purpose of calculating the ZZR. The previous formula was based purely on the 10-year average historical zero-coupon euro swap rate and required further creation of considerable reserves despite the fact that interest rates are no longer in decline. In our previous update note, we had highlighted that the German regulator (BaFin) was considering a formula adjustment that would be effective from 2018 and this has now materialised. This limits movements in the reference rate to a certain range, which is dependent on the current interest rates observed in the market and as a result, the rate went down from 2.21% to 2.09%, lowering the creation of new reserves in the German insurance industry for 2018 to €5.0bn from c €20.0bn based on the previous regulations (according to BaFin). This has assisted NBG’s results as well, with a lower increase in ZZR at €61.3m (vs €241.3m in FY17). The regulatory change (although anticipated by management) was not factored into management guidance. Assuming a constant level of interest rates, the ZZR will further grow in 2019 (albeit to a lesser extent in comparison to the prior formula) and after a few years should start declining (although a bit later and more gradually). It is worth noting that NBG’s future obligations from life insurance products are relatively limited due to a high proportion of unit-linked and disability business.

The P&C segment (23% of gross premiums in FY18) reported an increase in new premiums at 11.2% y-o-y to €115.3m, assisted by the consolidation of NRV. As a result, gross premiums booked went up 10.1% yoy to €785.4m. Insurance claims declined marginally to €344.7m from €349.0m in FY17 (excluding NRV, these numbers stand at €407.7m and €425.3m, respectively), which was particularly driven by the liability and vehicle insurance products. This translated into an improved combined ratio, which stood at 91.4%, down from 95.3% in FY17. Having said that, the lack of certain one-off effects (distribution from a special fund), which supported FY17 results, and the increase in equalisation reserves by €15.3m (vs a decline of €12.5m in FY17) had a negative impact on segment results. Together with the 6.5% y-o-y increase in operating expenses to €192.0m (although mostly due to NRV consolidation), this translated into a lower segment result of €23.9m vs €31.8m in FY17. Still, this was moderately ahead of management guidance of €22.0m.

The segment profit in Health Insurance stood at €4.5m in 2018 vs €4.0m in FY17, in line with management expectations. New premiums went up slightly to €10.5m from €10.2m in FY17 (vs expectations of a small decline), driven mainly by full insurance products. Gross premiums booked stood at €219.5m vs €217.7m in FY17. Here, NBG is putting strong emphasis on its student offering and supplementary long-term care insurance. The decline in the Banking Services segment result to €4.1m from €5.3m in FY17 was less pronounced than management had expected.

Outlook: Gross premium growth assisted by P&C

The German insurance industry (in particular life insurance business) continues to be affected by the low interest rate environment (weighing on investment income and demand for long-term pension products) as well as regulatory burdens. The potential changes to the life insurance regulations referred to as Lebensversicherungsreformgesetz II (LVRG II) may involve the introduction of a cap on fees earned on life insurance contracts and constrain the new business. According to GDV, gross premiums booked in the life insurance business should increase by c 1% in 2019. In line with the above, NBG expects a stable level of premiums booked in FY19 and guides to a segment profit of €38m (which implies a 14% decline from FY18). Premiums in the German P&C business should rise by c 3% (according to GDV), with NBG also expecting solid new business, especially in the commercial segment (following the efficiency measures introduced in FY18), as well as vehicle and casualty insurance. At the same time however, the NBG guides to a decrease in segment profit to €15m (vs €23.9m in FY18) due to higher equalisation reserves and reduced investment income. Together with the Health Insurance (profit guidance at €5.0m vs €4.5m in FY19) and Banking Services segment (profit to remain stable), this should result in group net profit at €55m in FY19, according to company guidance.

Valuation

As there are no Refinitiv consensus estimates for NBG, our P/E calculations for 2018 are based on management’s FY19 net profit guidance of €55m. We feel it is an appropriate measure as management expectations appear relatively conservative, as exhibited by the FY18 earnings beat. Based on these figures, the company is trading at c 40% premium to the peer group. NBG pays out an annual dividend of €3 per share, implying a 4.3% yield, which is a c 18% premium to peers.

Exhibit 2: Peer group comparison

Market cap (lcy m)

Share price (lcy)

P/E

Dividend yield

2019e

2020e

2019e

2020e

UNIQA Insurance Group

2,753.8

8.88

12.2

11.3

6.2%

6.5%

Helvetia Holding

6,066.5

610.00

12.1

11.7

4.1%

4.3%

Baloise Holding

7,930.0

162.50

12.5

11.4

3.9%

4.2%

Ageas

8,676.6

42.56

9.9

9.3

5.3%

5.7%

Swiss Life Holding

14,793.6

431.40

12.5

11.5

4.3%

4.8%

NN Group

12,380.6

36.15

9.1

8.4

5.7%

5.9%

CNP Assurances

13,465.5

19.53

9.9

9.6

4.6%

4.8%

AXA

54,472.9

22.37

8.1

7.7

6.5%

6.8%

Allianz

84,213.8

197.58

10.5

9.8

4.8%

5.1%

Talanx

8,615.3

34.08

9.3

8.6

4.5%

4.9%

Peer group average

10.6

9.9

5.0%

5.3%

Nürnberger Beteiligungs

817.9

71.00

14.9*

N/A

4.2%**

N/A

Premium/(discount)

40.2%

N/A

18.2%

N/A

Source: Refinitiv consensus at 27 March 2019. Note: *Ratio has been calculated based on management guidance. **Yield calculated based on dividend proposal from 2018 earnings.

General disclaimer and copyright

This report has been prepared and issued by Edison. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the Edison analyst at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd who holds an Australian Financial Services Licence (Number: 427484). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

Neither this document and associated email (together, the "Communication") constitutes or form part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities, nor shall it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. Any decision to purchase shares in the Company in the proposed placing should be made solely on the basis of the information to be contained in the admission document to be published in connection therewith.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document (nor will such persons be able to purchase shares in the placing).

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a) (11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been prepared and issued by Edison. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the Edison analyst at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd who holds an Australian Financial Services Licence (Number: 427484). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

Neither this document and associated email (together, the "Communication") constitutes or form part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities, nor shall it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. Any decision to purchase shares in the Company in the proposed placing should be made solely on the basis of the information to be contained in the admission document to be published in connection therewith.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document (nor will such persons be able to purchase shares in the placing).

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a) (11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

This paragraph mark is needed to maintain formatting, please leave this text for the editors.

More on Nurnberger Beteiligungs

View All

Latest from the Financials sector

View All Financials content

ASIT biotech — All the bases loaded for ASIT011

ASIT’s FY18 preliminary results were dominated by the initiation of the second Phase III study of gp-ASIT+ where randomisation is now complete. The company’s FY18 operating loss increased slightly to €12.8m compared to FY17. R&D comprised the bulk of operating expense at €10.9m and included €9.9m on the Phase III study. Cash at the end of FY18 and March 19 was €8.5m and €5.9m, respectively, while the previously announced convertible note offering should extend the cash runway from Q319 until Q320.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free